GlaxoSmithKline, J&J to Start Rheumatoid Arthritis Drug Trial

GlaxoSmithKline and Johnson & Johnson’s Janssen Biologics said Thursday they have begun late-stage trial testing of a new treatment for moderately active to severely active rheumatoid arthritis.
Reuters